2019
DOI: 10.24287/1726-1708-2018-17-4-57-63
|View full text |Cite
|
Sign up to set email alerts
|

Sinonasal renal cell-like adenocarcinoma

Abstract: A case of clinical observation of a Sinonasal Renal Cell-like Adenocarcinoma in a patient of 17 years is described. In the article the description of the case of Sinonasal Renal Cell – like Adenocarcinoma is described for the first time in the domestic literature and clinical and histological features are analyzed in detail. Patient's parents agreed to use personal dats and photos in research and publications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…There is no straight way for reporting the epidemiology of orofacial malignancies worldwide given the inconsistency in reporting cancerous lesions [1][2][3][4] and the continuous reappraisal of the histomorphologically similar lesions that proved to be cytogenetically separate entities (e.g., acinic cell carcinoma and mammary analog secretory carcinoma [5][6][7]). Complicating the matters, the introduction of new orofacial lesions (e.g., Adamantinoma-like Ewing sarcoma of the salivary glands [8,9], mammary analog secretory carcinoma [10][11][12][13][14], Renal Cell-Like Adenocarcinoma [15][16][17], HPV-related multiphenotypic sinonasal carcinoma, with adenoid cystic carcinoma-like features [18][19][20][21][22], Microsecretory Adenocarcinoma [23][24][25][26][27], ossifying fibromyxoid tumor [28,29] and Oncocytic intraductal carcinoma [23]) could not be mastered by all head and neck pathologists even in the USA [30]. Several epidemiologic efforts have been exerted to report orofacial malignancies in Libya, UAE [31], Saudi Arabia [2,32] and other Middle Eastern countries [33]either at the uni-institutional level or at the multi-institutional level [34].…”
Section: Introductionmentioning
confidence: 99%
“…There is no straight way for reporting the epidemiology of orofacial malignancies worldwide given the inconsistency in reporting cancerous lesions [1][2][3][4] and the continuous reappraisal of the histomorphologically similar lesions that proved to be cytogenetically separate entities (e.g., acinic cell carcinoma and mammary analog secretory carcinoma [5][6][7]). Complicating the matters, the introduction of new orofacial lesions (e.g., Adamantinoma-like Ewing sarcoma of the salivary glands [8,9], mammary analog secretory carcinoma [10][11][12][13][14], Renal Cell-Like Adenocarcinoma [15][16][17], HPV-related multiphenotypic sinonasal carcinoma, with adenoid cystic carcinoma-like features [18][19][20][21][22], Microsecretory Adenocarcinoma [23][24][25][26][27], ossifying fibromyxoid tumor [28,29] and Oncocytic intraductal carcinoma [23]) could not be mastered by all head and neck pathologists even in the USA [30]. Several epidemiologic efforts have been exerted to report orofacial malignancies in Libya, UAE [31], Saudi Arabia [2,32] and other Middle Eastern countries [33]either at the uni-institutional level or at the multi-institutional level [34].…”
Section: Introductionmentioning
confidence: 99%